The Korean Society of Pulmonary Hypertension "Early diagnosis, professional treatment, and precision medical research"
Jul 23, 2024
|
In addition to the introduction of the conference, ▲ Policy suggestions for specialized treatment of pulmonary hypertension in Korea ▲ Lung, Family Hope Campaign to Improve Disease Awareness ▲ OPUS-K research planning proposals to overcome ultimate pulmonary hypertension were presented.
Kim Ki-beom, academic director of the Korean Society of Pulmonary Hypertension, said "This year's conference will be held in advance with pulmonary hypertension, treat it properly, and stay happy! Under the theme of 'Aware Early, Treat Properly, Stay Happy!', 343 people from 21 countries and about 500 people including field registrants participated in 18 sessions. "It is a venue for cooperation among medical staff from various fields such as cardiology, pediatrics, rheumatology, and respiratory medicine to discuss multidisciplinary treatment. A joint session with the Korean Society of Vascular Medicine (KOVAS) and the Korean Society of Cardiac Failure (KSHF) was also held to consider how to overcome pulmonary hypertension and the latest treatment."," he said, expressing the meaning of the conference.
Kim Dae-hee, the policy director, then emphasized the government's active support for the introduction of new drugs, 'health insurance benefits', and 'establishment of specialized centers' under the theme of 'policy for overcoming pulmonary hypertension in Korea'.
Policy Director Kim Dae-hee said "As actively used overseas treatments have not yet been introduced in Korea, it is expected to change the game of domestic pulmonary arterial hypertension treatment options, which have only been controlled by symptoms when introduced and used in Korea."He emphasized the need to introduce new drugs. In addition, he urged the rapid provision of new and pediatric pulmonary arterial hypertension drugs, which are currently non-paying, and at the same time, expressed the society's position on the designation of a pulmonary hypertension center, saying, `It is difficult to find a hospital with a multidisciplinary team, let alone a pulmonary hypertension prescription center in Korea.'
The society is also developing a 'Lung, Family Hope Campaign' for the public to improve awareness of pulmonary hypertension diseases.
"Pulmonary hypertension is a disease in which early detection and treatment through more accurate diagnosis are important. As part of the campaign project, educational materials on the diagnosis and treatment of pulmonary hypertension are developed and distributed and educated for medical staff, and public education videos are produced so that patients can visit appropriate hospitals and spread through YouTube of the conference."," he said. The society will continue its campaign activities to provide accurate information on the disease, he added.
Finally, Chairman Jung Wook-jin (Professor of Cardiology at Gachon University of Medicine) proposed 'OPUS-K' to the government to fundamentally overcome pulmonary hypertension, an incurable disease. This project is a key mid- to long-term project of the society, which aims to increase the survival rate of pulmonary hypertension in Korea to the world's best by raising the compliance rate of pulmonary hypertension treatment guidelines in Korea to the level of developed countries.
Regarding the (tentative name) OPUS-K project, Chairman Jung Wook-jin emphasized, "We would like to carry out four tasks: finding and brokering a large diagnostic biomarker and treatment target in detail, establishing an international cooperation system for precision medicine, randomized clinical studies to create evidence, and implementing studies to improve compliance rates with medical guidelines through this project, which is expected to improve the 5-year survival rate of refractory pulmonary hypertension, which lags behind advanced countries such as the United States, the United Kingdom, and Japan by more than 95%, especially in patients with pulmonary hypertension" "Although it still tends to be below the global level, in Korea, the current pulmonary arterial hypertension can expect a survival rate of more than 70% if diagnosed early, so the selection of topics and continuous support from the government's mid- to long-term research projects such as K-ARPA-H for OPUS-K (tentative name) are essential to strengthen expertise in early diagnosis and treatment and management."
Pulmonic Hypertension (PH) is an incurable disease caused by various causes in 1% of the world's population, and it is estimated that about 500,000 people in Korea.
Pulmonary hypertension, a type of pulmonary hypertension (one of five groups according to the WHO classification), is estimated to be about 6000 people, with a 5-year survival rate in Korea of about 72% and an average survival period of 13.1 years, which has improved significantly compared to the past. However, compared to the survival rate of pulmonary arterial hypertension in advanced countries such as Japan reaching more than 85%, more active efforts are still needed.
Meanwhile, the 9th Korean Pulmonary Hypertension Society conference was held simultaneously with the 4th East Asian Pulmonary Hypertension Society conference, and more than 500 experts, including 93 foreigners from 23 countries, including Korea, Japan, China, and Taiwan, participated to actively discuss improving the survival rate of pulmonary hypertension.
|
bellho@sportschosun.com
